Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
You are in: eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Pharmacology

Topical Anesthetics, Cocaine

Last Updated: October 26, 2005
Email to a Colleague
Synonyms and related keywords: topical anesthetics, topical anesthesia, anesthesia, local anesthesia, anesthetic, local anesthetic, numbing agent, coca, coca plant, Erythroxylum coca, Erythroxylon coca, E coca, vasoconstrictor, vasoconstriction agents, cocaine hydrochloride, cocaine hcl, TCA topical solution

  AUTHOR INFORMATION Section 1 of 9    Click here to go to the next section in this topic
Author Information Introduction And History Mechanism Of Action Absorption And Metabolism Clinical Uses Toxicity And Adverse Reactions Management Of Toxicity Pictures Bibliography

Author: Don R Revis, Jr, MD, Consulting Staff, Department of Surgery, Division of Plastic and Reconstructive Surgery, University of Florida College of Medicine

Coauthor(s): Michael Brent Seagle, MD, Associate Professor, Division of Plastic Surgery, University of Florida College of Medicine; Consulting Staff, Florida Surgical Center

Don R Revis, Jr, MD, is a member of the following medical societies: American College of Surgeons, American Medical Association, American Society for Aesthetic Plastic Surgery, and American Society of Plastic Surgeons

Editor(s): Terry Tsue, MD, Program Director, Associate Professor, Department of Otolaryngology-Head and Neck Surgery, University of Kansas School of Medicine; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Dominique Dorion, MD, Program Director and Division Chairman, Professor of Surgery, Division of Otolaryngology, University of Sherbrooke, Canada; Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders; and Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Disclosure
  INTRODUCTION AND HISTORY Section 2 of 9   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction And History Mechanism Of Action Absorption And Metabolism Clinical Uses Toxicity And Adverse Reactions Management Of Toxicity Pictures Bibliography

Cocaine is an alkaloid derived from the leaves of the coca plant (Erythroxylon coca). It is the only naturally occurring local anesthetic in medical use today. Indigenous to the Andes Mountains, West Indies, and Java, its use was touted over the centuries as a method of reducing fatigue and promoting a sense of well-being.

Cocaine was introduced into Europe in the 1800s. Sigmund Freud used cocaine on his patients and became addicted through self-experimentation. Niemann first isolated and purified cocaine in 1859. In the latter half of the 1800s, widespread interest in cocaine developed among the medical community, and, during this period, many of the pharmacologic actions and adverse effects were elucidated.

In the 1880s, Koller introduced cocaine into the practice of ophthalmology and Hall introduced it to dentistry.

Cocaine was widely available at the outset of the 20th century, and Coca-Cola contained approximately 4.5 mg/180 mL. With widespread use, the problems of abuse and addiction became apparent, and the Harrison Narcotics Act of 1914 essentially banned distribution of cocaine in the United States, except by prescription.

Today, cocaine continues to be used for recreational and medical purposes. Medical use is confined primarily to operative procedures of the nose and throat and treatment for dermal lacerations in children.
  MECHANISM OF ACTION Section 3 of 9   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction And History Mechanism Of Action Absorption And Metabolism Clinical Uses Toxicity And Adverse Reactions Management Of Toxicity Pictures Bibliography

Cocaine produces anesthesia by inhibiting excitation of nerve endings or by blocking conduction in peripheral nerves. This is achieved by reversibly binding to and inactivating sodium channels. Sodium influx through these channels is necessary for the depolarization of nerve cell membranes and subsequent propagation of impulses along the course of the nerve. When a nerve loses its ability to propagate an impulse, the individual loses sensation in the area supplied by the nerve.

Cocaine also has a profound effect on the CNS. Cocaine blocks reuptake of dopamine in the midbrain region responsible for reward mediation. This leads to increased stimulation and a sense of euphoria and arousal. As the cocaine level decreases, so does the dopamine level in this region, resulting in depression and a craving for the drug.

Cocaine also blocks the reuptake of norepinephrine in the sympathetic portion of the autonomic nervous system, resulting in increased stimulation of the sympathetic nervous system. This results in the characteristic tachycardia, hypertension, diaphoresis, mydriasis, and tremors associated with cocaine use.

Cocaine is the only local anesthetic with vasoconstrictive properties. This is a result of its blockade of norepinephrine reuptake in the autonomic nervous system.
  ABSORPTION AND METABOLISM Section 4 of 9   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction And History Mechanism Of Action Absorption And Metabolism Clinical Uses Toxicity And Adverse Reactions Management Of Toxicity Pictures Bibliography

Cocaine is absorbed rapidly through mucous membranes, and peak plasma levels (ie, 20-474 ng/mL) are reached within 15-60 minutes. Half-life in serum is 30-90 minutes.

Cocaine is metabolized in several ways. Hydrolysis by plasma pseudocholinesterases accomplishes the majority of cocaine degradation to benzoylecgonine and ecgonine methyl ester.

Oxidative metabolism in the liver produces norcocaine, a toxic substance capable of causing severe hepatic damage. Approximately 5% of absorbed cocaine is excreted in the urine unmetabolized.

Cocaine is detectable in the nasal mucosa for 3 hours following application. Serum and urine levels are measurable for approximately 6 hours following application.



Quick Find
Author Information
Introduction And History
Mechanism Of Action
Absorption And Metabolism
Clinical Uses
Toxicity And Adverse Reactions
Management Of Toxicity
Pictures
Bibliography

Click for related images.

Patient Education
Click here for patient education.



  CLINICAL USES Section 5 of 9   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction And History Mechanism Of Action Absorption And Metabolism Clinical Uses Toxicity And Adverse Reactions Management Of Toxicity Pictures Bibliography

Cocaine is used for topical anesthesia and vasoconstriction for surgery of the nose, throat, and oral cavity. Cocaine provides rapid and profound anesthesia in conjunction with vasoconstriction and decongestion of swollen mucosa.

Cocaine hydrochloride is available commercially in the United States as flakes, crystals, 135-mg tablets, and solutions of various concentrations. The flakes and crystals are intended for application via moistened cotton swabs. The tablets are to be used in preparation of a topical solution. The premade topical solutions are available in strengths ranging from 2-10%.

The safe maximum dosage is reported to be 200 mg or 2-3 mg/kg. However, even 200 mg can cause adverse reactions if rapidly absorbed. Spraying or painting cocaine on the intended surgery site causes more rapid absorption than application by patch or pledget. Clinical studies have shown that only approximately one third of a cocaine solution placed on pledgets is absorbed via the nasal mucosa, providing an added margin of safety for the surgeon.

When epinephrine is added to the solution to promote further vasoconstriction, systemic absorption decreases; however, according to published series, the decrease is inconsistent. Late absorption of cocaine has also been reported when cocaine is administered with epinephrine. Therefore, the use of epinephrine cannot be assumed to protect from systemic cocaine absorption. The addition of epinephrine has also been reported to enhance the sympathomimetic action of cocaine, causing hypertension and tachyarrhythmias.

To use cocaine in the nasal cavity, cotton pledgets are soaked in the cocaine solution. After being wrung out, the pledgets are introduced into the operative field with bayonet forceps. Pay particular attention to placing the pledgets in contact with the mucosal surface.

After the pledgets have been in place for at least 10 minutes, they may be removed from the side to be approached first. Infiltration of submucosal lidocaine with epinephrine may then be performed. This is best performed with a small syringe and 25-gauge or smaller needle. Proper placement creates blanching of the mucosa. Rarely is more than 1.5 mL required for each side. After allowing several minutes for the injected solution to take effect, inspect the mucosa for the anticipated vasoconstriction. If the patient reports pain at this time or further along in the operative course, pledgets may be loosely reapplied.

Another more recently developed use of cocaine is in combination with tetracaine and adrenaline (TAC), composed of 0.5% tetracaine, epinephrine 1:200,000, and 11.8% cocaine. This combination has been used in the pediatric population for suturing lacerations less than 10 cm long in the emergency department. It has been found to be most effective in the head, neck, and scalp; less effective in the trunk; and ineffective in the extremities.

A few drops of the solution may be placed directly on the wound, or, preferably, a moistened cotton ball soaked in the solution may be applied to the wound. Constant gentle pressure is then applied to the cotton balls for 10-20 minutes. After testing the adequacy of anesthesia, the wound may be irrigated, cleansed, and sutured. Inadequacy of anesthesia is remedied by injection of local anesthetic.

Monitor the patient with pulse oximetry and telemetry during use of TAC. In addition, observe the patient for any signs or symptoms of systemic toxicity. Following application and suturing, observe the patient for an additional 60 minutes to ensure that no untoward effects of cocaine absorption occur.

The benefits of TAC include ease of application, patient comfort during application, and avoidance of wound distortion from the injection of local anesthetic solution. This technique has been proven safe and effective in numerous published studies and is gaining wide popularity among emergency departments. TAC should not be used on mucous membranes, burns, or large abrasions because of the risk of rapid absorption and systemic toxicity.
  TOXICITY AND ADVERSE REACTIONS Section 6 of 9   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction And History Mechanism Of Action Absorption And Metabolism Clinical Uses Toxicity And Adverse Reactions Management Of Toxicity Pictures Bibliography

Although adverse reactions to cocaine seldom occur in the medical field, those that do may be rapid, unexpected, and severe. Other good alternatives for anesthesia are available, and many surgeons have ceased using cocaine because of its unpredictable effects and the risk of having such a highly addictive drug in the office.

Cocaine toxicity may have profound adrenergic effects on the CNS, cardiovascular system, and respiratory system. Sympathetic stimulation of the cardiovascular system may lead to hypertension, tachycardia, ventricular fibrillation, and cardiac arrest. Other serious complications include direct cardiotoxicity, angina, myocardial infarction, cerebrovascular accident, transient ischemic attack, pulmonary edema, hepatotoxicity, intestinal ischemia, seizures, and CNS depression.

Cocaine readily passes into breast milk and across the placenta, an important consideration in patients who are pregnant or nursing. Stillbirth, preterm labor, and abruptio placentae may occur. Intrauterine growth is also restricted. These often-profound effects on the fetus may continue after birth. Developmental delay is common in children born to mothers with cocaine in their system.
  MANAGEMENT OF TOXICITY Section 7 of 9   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction And History Mechanism Of Action Absorption And Metabolism Clinical Uses Toxicity And Adverse Reactions Management Of Toxicity Pictures Bibliography

The cornerstone of treatment for cocaine toxicity is early recognition and action. The treating physician must curtail the operative procedure and remove any remaining pledgets. Immediately activate advanced cardiac life support protocols, including intubation and defibrillation if indicated.

Above all, seek help immediately. In a hospital setting, assistance is readily available. In the office surgery setting, call emergency services (ie, dial 911 in the United States) immediately. The surgeon must direct resuscitation until assistance arrives. This requires that any surgeon using cocaine in the office be familiar with advanced cardiac life support protocols and have the proper equipment on hand should an emergency situation arise.

Cocaine toxicity has no known antidote. Aggressive resuscitation is the only treatment. In addition to intubation and defibrillation, administering drugs such as propranolol, nitrates, calcium channel blockers, and alpha-adrenergic blockers may be necessary in an attempt to improve coronary blood flow and restore normal sinus rhythm. Control seizure activity with diazepam (Valium), and aggressively treat hyperthermia with cooling blankets.
  PICTURES Section 8 of 9   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction And History Mechanism Of Action Absorption And Metabolism Clinical Uses Toxicity And Adverse Reactions Management Of Toxicity Pictures Bibliography

Caption: Picture 1. Topical anesthetics, cocaine. Chemical structure of cocaine.
Click to see larger pictureClick to see detailView Full Size Image
Picture Type: Graph
  BIBLIOGRAPHY Section 9 of 9   Click here to go to the previous section in this topic Click here to go to the top of this page
Author Information Introduction And History Mechanism Of Action Absorption And Metabolism Clinical Uses Toxicity And Adverse Reactions Management Of Toxicity Pictures Bibliography

  • Albers FW: The clinical use of cocaine in rhinosurgery: a case-report and a review. Rhinology 1990 Mar; 28(1): 55-9[Medline].
  • Aldous WK, Jensen R, Sieck BM: Cocaine and lidocaine with phenylephrine as topical anesthetics: antimicrobial activity against common nasal pathogens. Ear Nose Throat J 1998 Jul; 77(7): 554-7[Medline].
  • Batai I, Kerenyi M, Tekeres M: The impact of drugs used in anaesthesia on bacteria. Eur J Anaesthesiol 1999 Jul; 16(7): 425-40[Medline].
  • Benowitz NL: Clinical pharmacology and toxicology of cocaine. Pharmacol Toxicol 1993 Jan; 72(1): 3-12[Medline].
  • Emslander HC: Local and topical anesthesia for pediatric wound repair: a review of selected aspects. Pediatr Emerg Care 1998 Apr; 14(2): 123-9[Medline].
  • Fox AJ, Rowbotham DJ: Anaesthesia. BMJ 1999 Aug 28; 319(7209): 557-60[Medline][Full Text].
  • Grant SA, Hoffman RS: Use of tetracaine, epinephrine, and cocaine as a topical anesthetic in the emergency department. Ann Emerg Med 1992 Aug; 21(8): 987-97[Medline].
  • Greinwald JH Jr, Holtel MR: Absorption of topical cocaine in rhinologic procedures. Laryngoscope 1996 Oct; 106(10): 1223-5[Medline].
  • Hari CK, Roblin DG, Clayton MI, Nair RG: Acute angle closure glaucoma precipitated by intranasal application of cocaine. J Laryngol Otol 1999 Mar; 113(3): 250-1[Medline].
  • Hashisaki GT, Johns ME: Cocaine applications in otorhinolaryngologic anesthesia. Contemp Anesth Pract 1987; 9: 31-45[Medline].
  • Keyes PD, Tallon JM, Rizos J: Topical anesthesia. Can Fam Physician 1998 Oct; 44: 2152-6[Medline].
  • Latorre F, Klimek L: Does cocaine still have a role in nasal surgery? Drug Saf 1999 Jan; 20(1): 9-13[Medline].
  • Liao BS, Hilsinger RL Jr, Rasgon BM, et al: A preliminary study of cocaine absorption from the nasal mucosa. Laryngoscope 1999 Jan; 109(1): 98-102[Medline].
  • Minor RL Jr, Scott BD, Brown DD, Winniford MD: Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med 1991 Nov 15; 115(10): 797-806[Medline].
  • Mullin GS, Rubinfeld RS: The antibacterial activity of topical anesthetics. Cornea 1997 Nov; 16(6): 662-5[Medline].
  • Nathan B, McKeever J: Topical analgesia for children. J Accid Emerg Med 1997 Jan; 14(1): 59[Medline].
  • Roghani S, Duperon DF, Barcohana N: Evaluating the efficacy of commonly used topical anesthetics. Pediatr Dent 1999 May-Jun; 21(3): 197-200[Medline].
  • Singh V, Brockbank MJ, Todd GB: Flexible transnasal endoscopy: is local anaesthetic necessary? J Laryngol Otol 1997 Jul; 111(7): 616-8[Medline].
  • Vinci RJ, Fish S, Mirochnick M: Cocaine absorption after application of a viscous cocaine-containing TAC solution. Ann Emerg Med 1999 Oct; 34(4 Pt 1): 498-502[Medline].

Topical Anesthetics, Cocaine excerpt